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Mutations in the palm domain 
disrupt modulation of acid-
sensing ion channel 1a currents by 
neuropeptides
Benoîte Bargeton1, Justyna Iwaszkiewicz2, Gaetano Bonifacio1, sophie Roy1, Vincent Zoete  2,3 
& stephan Kellenberger  1
Modulation by neuropeptides enhances several functions of acid-sensing ion channels (ASICs), such 
as pain sensation and acid-induced neuronal injury. The acid-induced opening of ASICs is transient, 
because of a rapid desensitization. Neuropeptides containing an Arg-Phe-amide motif affect ASIC 
desensitization and allow continuous activity of ASICs. In spite of the importance of the sustained 
ASIC activity during prolonged acidification, the molecular mechanisms of ASIC modulation by 
neuropeptides is only poorly understood. To identify the FRRFa (Phe-Arg-Arg-Phe-amide) binding 
site on ASIC1a, we carried out an in silico docking analysis and verified functionally the docking 
predictions. The docking experiments indicated three possible binding pockets, located (1) in the 
acidic pocket between the thumb, finger, β-ball and palm domains, (2) in a pocket at the bottom of 
the thumb domain, and (3) in the central vestibule along with the connected side cavities. Functional 
measurements of mutant ASIC1a confirmed the importance of residues of the lower palm, which 
encloses the central vestibule and its side cavities, for the FRRFa effects. The combined docking and 
functional experiments strongly suggest that FRRFa binds to the central vestibule and its side cavities 
to change ASIC desensitization.
Acid-sensing ion channels (ASICs) are voltage-independent Na+ channels that are activated by extracellular acid-
ification1–3. ASICs are expressed in the central and peripheral nervous system and contribute to the expression of 
fear, learning, neurodegeneration after ischemic stroke and to pain sensation1,2,4. The subunits ASIC1a, -1b, -2a, 
-2b and 3 can assemble into functional homo- or heterotrimeric channels whose biophysical properties such as 
pH dependence and current kinetics depend on their subunit composition1,2. ASICs were shown to be involved 
in processes associated with sustained acidification, such as inflammatory pain sensation and ischemic neuronal 
damage1,5,6. These roles require a sustained channel activity upon continuous acidification. However, extracellular 
acidification activates ASICs only transiently, because these channels enter rapidly a desensitized, non-conducting 
state. A small sustained current component is only observed in ASIC3 and in some heteromeric ASICs.
ASICs belong to the epithelial Na+ channel (ENaC)/degenerin ion channel family, whose members form 
Na+-permeable ion channels that are inhibited by amiloride2. The ENaC/degenerin family member FaNaC is 
a molluscan ion channel that is activated by the neuropeptide Phe-Met-Arg-Phe-amide (FMRFa)7. FaNaC-like 
channels have been described in mollusks and Hydra8–10, but not in mammals. Mammals express FMRFa-related 
peptides that exert their pharmacological actions mainly by binding to G protein-coupled receptors11. 
Mammalian FMRFa-like peptides contain more than four residues. Since they share the characteristic C-terminus 
motive Arg-Phe-NH2, they are also called “RFamide (RFa) peptides”12. ASIC modulation by RFa peptides has 
been documented in different heterologous expression systems, in neurons and in animal studies7,13–15. FMRFa 
and related peptides slow the desensitization time course of ASIC1- and ASIC3-containing channels and induce 
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a sustained (non-desensitizing) current as well as an acidic shift in the SSD pH dependence of ASIC1a. The 
C-terminal amide group of RFa peptides is necessary for the effects on ASICs16,17.
Crystal structures of chicken ASIC1 show that the three subunits are arranged around the central pore. 
The shape of the single subunits has been compared to a forearm and a clenched hand holding a small ball. 
Accordingly, the different extracellular domains have been named thumb, finger, knuckle, β-ball and palm18,19 
(Fig. 1a,b). The palm and β-ball form a β-strand-rich scaffold around the central vertical axis of the channel 
trimer. The lower palm domains enclose a large internal cavity in the trimer, termed “central vestibule”. The 
thumb and the finger form the outer, α-helix-rich channel domains, enclosing an area of high electronegativity 
named “acidic pocket”18 that collapses upon extracellular acidification20. Extracellular pH changes affect the pro-
tonation status of several amino acid residues located in different domains, such as the acidic pocket, the palm 
and the wrist, contributing thereby to activation and desensitization of the channel18,21–25. The palm domain 
undergoes large conformational changes during desensitization; its integrity is required for a normal, complete 
desensitization16,22,25–27.
Currently it is not known where in the ASICs the RFa peptides bind. Structure-function studies showed that 
residues in the thumb and the palm co-determine the effect of RFa peptides16,28, however it is not clear whether 
these domains participate in the formation of the binding site or whether they are important for transducing 
binding into functional effects. To identify potential RFa peptide binding sites on ASIC1a, we conducted in silico 
docking experiments on a human ASIC1a model with the peptide FRRFa28, which robustly modulates ASIC cur-
rents. Our docking studies predicted possible binding sites in the acidic pocket, a pocket at the thumb base, and 
in the side cavities of the central vestibule. Mutagenesis of residues being part of predicted binding sites, followed 
by functional analysis, demonstrated impairment of FRRFa effects in ASICs carrying mutations in the central 
vestibule or its side cavities, strongly suggesting this as the binding site for FRRFa.
Results
Molecular docking to a desensitized ASIC model predicts FRRFa binding to the acidic pocket as 
most probable. The in silico docking experiments were initially carried out with human ASIC1a homology 
models based on the desensitized and open chicken ASIC1 structures18,29, and the mutagenesis approaches in this 
study were based on these docking results. A crystal structure of closed ASIC, which may be more relevant in 
this context since RFa peptides need to be pre-applied in the pH 7.4 solution to affect ASIC current properties15, 
became available only very recently20. When discussing here the docking results, we present briefly the docking 
results on the desensitized or open ASIC1a model to illustrate the basis of the mutagenesis strategy, and then in 
more detail the results obtained with the ASIC model in the closed conformation.
Molecular docking was carried out with the program AutoDockVina23, on the trimeric ASIC1a structure 
comprising residues 65–432, in which the lower transmembrane and the intracellular parts were omitted (see 
Methods). The docking poses with the most favourable energy according to the internal ranking of the program 
were further investigated. Docking of FRRFa to the desensitized ASIC1a conformation highlighted two different 
cavities as most probable binding pockets, the acidic pocket and a cavity at the base of the thumb that we call here 
“thumb base pocket”. The docking poses in the acidic pocket (Fig. 1a) showed the most favourable docking score. 
The peptide docked to the acidic pocket in numerous different orientations, which were ranked closely to each 
other by the docking software. Since RFa peptides that contain more than four residues carry the RFa motif at the 
C-terminus, poses that would also be relevant for longer RFa peptides should have their N-terminal end pointing 
towards the outside of the pocket. Among the docking solutions whose score was within 1 kcal/mol from the best 
scored pose, we found several types of poses fulfilling the above criterion, one example is shown in Fig. 1c. In 
these poses, FRRFa interacts with several acidic residues (E97, D237, E242, E355), and other hydrophilic residues. 
Only sparse interaction is found for the two Phe residues of the peptide.
Docking to the closed ASIC1a conformation shows different poses in the acidic pocket. In the 
closed conformation, the acidic pocket adapts an extended conformation, with the thumb α5 helix moved away 
from the centre of the acidic pocket, and the finger loop 229–244 shifted away from the α3 finger helix when 
compared with the open or desensitized conformations (Fig. 1c,d)20. This leads to a ∼2.3-fold increase of the 
volume of the acidic pocket compared to the desensitized conformation (calculated with CASTp30, see Methods) 
and exposes several hydrophobic residues. To select FRRFa binding positions which could also be accessible to 
longer RFa peptides, we carried out docking experiments with the related, but longer peptide KNFLRFa17. We 
then superimposed the complexes of ASIC1a and highest scored conformations of FRRFa (score within less than 
1 kcal/mol of maximal score) with all the complexes of ASIC1a and the KNFLRFa peptide, and selected poses in 
which the RMSD values between the RFa moieties of both peptides was less than 1 Å. This yielded two poses in 
the acidic pocket (Fig. 1d–g, Supplementary Fig. S1a,b).
In contrast to the pose obtained in the desensitized state (Fig. 1c), the selected poses in the closed confor-
mation show a peptide that does not interact with the α5-helix, but is located higher up in the acidic pocket and 
interacts with the finger loop, and with other parts of the finger or with the β-ball of the neighbouring subunit 
(Fig. 1d–g). In the first selected FRRFa pose in the acidic pocket (Fig. 1d,e), the N-terminal Phe is involved in 
hydrophobic interactions with Leu230 and in a hydrogen bond with the Leu95 backbone. The second Arg forms 
a hydrogen bond with the Tyr191 hydroxyl group, whereas Arg3 forms a hydrogen bond with the backbone of 
Glu113 and the side chain of Thr236. The C-terminal Phe interacts via stacking and hydrophobic interactions 
with Tyr342 and hydrophobic contacts with Leu114 and the hydrophobic part of the Glu328 side chain. In the 
second pose, the N-terminal Phe is involved in hydrophobic interactions with Gly215 and Thr214 (β-ball of 
neighbouring subunit), while the C-terminal Phe interacts with the side chain of Ala116 (in the finger domain). 
The amide function of Phe4 is involved in a hydrogen bond with Ser240 and the Arg residues and the peptide 
backbone form hydrogen bonds with the side chains of Glu97, Thr214, Asp409 and Glu242 (Fig. 1f,g).
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Figure 1. Docking of FRRFa peptide to the acidic pocket of the desensitized and closed conformation of ASIC1a. 
The human ASIC1a structural model is based for (a–c) on a desensitized chicken ASIC1 structure18, and for (d–g) 
on the closed chicken ASIC120. (a) General view of the channel, highlighting the location of cavities into which 
peptides may bind. The central vestibule, which is enclosed by the lower palm domain, is not indicated. Estimated 
volumes in the desensitized ASIC1a model are ∼1600 Å3 (acidic pocket), ∼1150 Å3 (thumb base pocket) and 
∼1400 Å3 (central vestibule, CASTp30). (b) Single subunit with structural domains indicated: transmembrane 
part (red), palm (yellow), β-ball (orange), knuckle (cyan), finger (purple) and thumb (blue). (c) Example of a 
predicted FRRFa interaction mode with the ASIC1a acidic pocket of the desensitized state, shown in a structural 
view. (d,e) One of two predicted FRRFa interaction modes with the acidic pocket of closed ASIC1a, shown in a 
structural view (d) and a schematic 2D representation (e) that illustrates the interactions between peptide and 
channel (PoseView42). The colours in the scheme generated by PoseView were adjusted – the peptide is coloured 
as in (d and f) and the hydrophobic interactions are presented in purple. The program PoseView does not apply 
exactly the same stringency in the detection of H-bonds as Chimera41, therefore there exist some differences in 
the H-bond attribution. (f,g) Example of the second predicted FRRFa interaction mode with ASIC1a in the closed 
conformation, in structural view (f) and schematic 2D representation (g). In (c,d and f) the different domains 
of ASIC subunits are coloured as in (b) for the subunit on the left, while the second subunit is shown in red. The 
peptide is shown in green, with light green at the N-terminus and dark green at the C-terminus; the heteroatoms 
of highlighted residues are colored in blue (nitrogen), red (oxygen) and white (hydrogen). Letters at the end of 
residue identifiers in (e and g) indicate the ASIC subunit (A, B or C). Residues that were mutated for the functional 
analysis are presented in ball and stick representation and labelled in bold.
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Mixed effects of acidic pocket mutations on ASIC1a modulation by FRRFa. ASIC1a function was 
measured by two-electrode voltage-clamp after recombinant expression in Xenopus oocytes. The channels were 
activated by a pH5 stimulation solution from a conditioning solution of pH7.4. FRRFa, present in both the pH7.4 
and pH5 solution, induced in ASIC1a a sustained current in a concentration-dependent manner, with an EC50 of 
37 ± 15 μM (Fig. 2a, n = 7–12). We measured the rate of FRRFa unbinding, as the disappearance of the sustained 
current after a 50-s incubation with 50 μM FRRFa, as 0.025 ± 0.005 s−1 (n = 8, Fig. 2b). The related peptide FMRFa 
was shown to affect ASIC1a currents only when pre-applied with the conditioning solution at pH 7.415. To deter-
mine the kinetics of FRRFa association on ASIC1a, we pre-applied the peptide at a concentration of 50 μM for dif-
ferent time periods in the conditioning solution and measured the sustained current fraction. These experiments 
showed kinetics with an association rate constant kon (Methods) of 162 ± 84 s−1 M−1 (n = 4, Fig. 2c). This shows 
Figure 2. FRRFa modulation of ASIC1a currents is only partially affected by acidic pocket mutations. (a) 
FRRFa concentration-response curve. Top, representative current traces. Bottom, Isust/Ipeak ratio induced by pH5 
as a function of the FRRFa concentration (pre-applied during 45–50 s and present in pH5 solution), n = 7–11. 
(b) Time course of disappearance of the FRRFa-induced Isust. FRRFa at 50 μM was applied for 45 s, and current 
was measured once every minute during washout with FRRFa-free solution. Exponential fit shown as solid line 
(n = 4, error bars are smaller than the symbols). (c) Time course of appearance of Isust. Oocytes were exposed for 
various durations to 50 μM FRRFa in the pH7.4 conditioning solution, before activation of ASIC currents with 
pH5, including 50 μM FRRFa. Exponential fit shown as solid line, n = 4. (d–f) and (i–k), all Cys mutants had 
been exposed during 3 min to 1 mM MTSET before the experiment. (d) Bar graph of the Isust/Ipeak ratio induced 
by pH5. Grey bars, control; red bars, after exposure to 50 μM FRRFa, n = 4–40. *p < 0.05, **p < 0.01, different 
from the same condition in WT; ###p < 0.001, ####p < 0.0001, the FRRFa-induced increase in Isust/Ipeak (see e,f) 
is different from this ratio in WT. (e) ratio of FRRFa-induced Isust/Ipeak increase by 50 μM FRRFa (n = 4–40). (f) 
ratio of FRRFa-induced Isust/Ipeak increase by 500 μM FRRFa (n = 5–11). (g) Representative current traces of WT 
ASIC1a obtained at the indicated pH conditions, without FRRFa (top), with 15 μM FRRFa in the conditioning 
solution (bottom). (h) pH dependence of steady-state desensitization (SSD). Normalized pH5-induced current 
amplitude plotted against the conditioning pH (n = 8). The lines represent fits to the Hill equation described in 
Methods, pH protocol illustrated in inset. FRRFa was administered during the conditioning period (55 s). (i) 
Midpoint of SSD curve (pHD50) values obtained in the absence of FRRFa (n = 4–12). *p < 0.05; ****p < 0.0001; 
different from WT. (j) Difference in pHD50 (pHD50FRRFa-pHD50ctrl), n = 4–12. (k) nHFRRFa/nHctrl ratio. The pHD50 
shifts and nH ratios of mutant channels were not different from those of WT.
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first that the pre-application of FRRFa is necessary for the induction of a sustained current, since no sustained 
current increase was measured if FRRFa was only present in the pH5 solution (time point “0” in Fig. 2c), and 
second, that the association of FRRFa with its binding site is slow.
As mentioned above, the choice of mutations was based on the docking to the desensitized state. We mutated 
acidic residues at the pocket entry that may attract the positively charged peptide and control the access to the 
acidic pocket (Asp347, Asp351, Glu355) and in addition the residues Glu97, Asp237, Ser240 and Glu242 that were 
predicted to interact with FRRFa. To be more flexible in creating side chains of different properties, these residues 
were mutated to Cys. The mutant channels were exposed to the positively charged sulfhydryl reagent [2-(tri-
methylamonium)ethyl] methanethiosulfonate (MTSET, 1 mM for 3 min) before testing the effects of FRRFa. This 
modification creates a positively charged, large side chain31 that is expected to electrostatically disturb the FRRFa 
binding, and provide steric hindrance at the positions of interest. ASIC currents were induced by an exposure 
to pH5 during 10–20 s. The exposure time was kept long enough for the current to reach a steady-state, and was 
longer in some mutants with slower desensitization. Between applications of the acidic solution, oocytes were 
kept for 45–55 s in extracellular control conditioning medium at pH7.4 with or without FRRFa. The sustained/
peak current amplitude ratio (Isust/Ipeak) at pH5, under control conditions (grey bars) and after exposure to 50 μM 
FRRFa (red, Fig. 2d), and the fold change of this ratio (Fig. 2e) show that the induction of sustained currents by 
50 μM FRRFa was decreased by the E97C-ET and D347C-ET mutations/modifications as compared to WT. At 
a tenfold higher concentration, the FRRFa-induced increase of the Isust/Ipeak ratio was still significantly smaller 
in D347C-ET than in WT, not however in E97C-ET (Fig. 2f), indicating that E97C-ET shifts the FRRFa EC50 to 
higher values, while D347C-ET suppresses the induction of a sustained current, or strongly increases the EC50 of 
FRRFa for this effect.
Moderate acidification can desensitize ASICs without apparent opening in a process that is called steady-state 
desensitization (SSD). The pH dependence of the SSD can be measured by exposing ASICs to a series of condi-
tioning solutions of increasingly acidic pH for ∼1 Min, followed each time by acidification to pH5, and plotting 
the pH5-induced current amplitude as a function of the conditioning pH (Fig. 2g,h). RFa peptides have been 
shown to shift the SSD pH dependence of ASIC1a to more acidic values28. The inclusion of FRRFa for 1 min at 
a concentration of 15 μM in the conditioning solution induced an acidic shift and lowered the steepness of the 
ASIC1a SSD curve (Fig. 2g,h). Several of the acidic pocket mutations/modifications shifted the midpoint of SSD, 
termed pHD50 value, with regard to WT in the absence of any peptide (Fig. 2i). The FRRFa-induced shift of the 
pHD50 (Fig. 2j) and the change in steepness of the SSD curve (represented by the Hill coefficient nH, Fig. 2k) on 
these mutants/modifications was however not different from that observed in WT. Taken together, this analysis 
shows that mutation/modification of only 2 of 7 residues in the acidic pocket was able to reduce the increase 
in the Isust/Ipeak ratio by FRRFa, and none of the tested mutations affected the FRRFa-induced shift of the SSD 
curve (Table 1). We consider it unlikely that FRRFa binds into the acidic pocket, since its functional effect is not 
prevented by mutation to Cys and subsequent attachment of a large, positively charged molecule to each of the 
residues D237, S240, E242, D351 and E355.
A possible FRRFa binding site at the thumb base. As the docking results in the acidic pocket were not 
validated with the functional experiments, we further investigated the binding predictions to the desensitized 
channel that had obtained lower scores. In these poses, the peptide is docked at the thumb base, which is situated 
close to the lower end of the two thumb helices and is accessible from the “back side” of the acidic pocket, as illus-
trated in Fig. 1a. Since the thumb base pocket is smaller than the acidic pocket, only the Phe residues were placed 
inside of the pocket in high scored binding modes. Using the same reasoning as for the acidic pocket docking 
results, that the N-terminus of the peptide should point outwards, we considered only the poses where the Phe4 
and the C-terminal amide were placed inside of the pocket. In such poses, the rest of the molecule interacts with 
ASIC1a residues near the pocket (Fig. 3a). FRRFa shows hydrophobic interactions with Phe257, Val187 and 
Phe302; Arg2 and -3 of the peptide form hydrogen bonds with the backbone of several residues.
In the closed state, the thumb base pocket has a similar volume as in the desensitized state. In the only highly 
ranked pose for which we detected similar conformations of the RFa moieties of FRRFa and KNFLRFa, FRRFa 
binds to about the same binding pocket as in the desensitized state, however its orientation is different (Fig. 3b,c 
and Supplementary Fig. S1c). Both Phe residues point towards the entrance of the cavity, while Arg3 is bur-
ied inside the pocket, and its guanidine moiety forms π-cation interactions with Phe188. Phe4 forms stacking 
interactions with Phe302, and the C-terminal amide group is involved in a hydrogen bond with the side chain 
of Ser199. The other specific interactions are the hydrogen bonds between the Arg3 side chain and the Val328 
backbone as well as between the N-terminal amino function and the backbone of Asp300 and Phe301.
Thumb base mutations do not prevent functional effects of FRRFa. To scan the pocket and pre-
dicted entrance area with mutagenesis, we chose the residues with a potential to form hydrophobic (Ile312, 
Val187), aromatic (Phe 257, Phe301, Phe302) or electrostatic (Glu254, Asp303, Ser199, Asp253, Glu315) interac-
tions with the peptide. For this analysis, we used mutation to Ala, and complemented the scan with mutation to 
Cys and subsequent chemical modification only for a selected residue. Analysis of the Isust/Ipeak ratio after FRRFa 
showed significantly higher values than in WT for F302A and D303A (Fig. 4a). The FRRFa-induced increase in 
Isust/Ipeak ratio was in none of the mutants significantly smaller than in WT, and was increased by the mutations 
S199A and F302A (Fig. 4b). Phe302 is part of a loop connecting palm and thumb domains in the close neigh-
bourhood of the thumb base. The observed increased Isust/Ipeak ratio of F302A (Fig. 4b,e) could simply be due to 
a better accessibility of the cavity of the putative RFa binding site in the thumb base, because Phe302 has a larger 
side chain than has Ala to which it was mutated. To test this hypothesis, we mutated Phe302 to Cys and exposed 
the mutant to the sulfhydryl reagent trimethylammonium-methyl methanethiosulfonate (MTSMT; 1 mM during 
3 min) before the exposure to FRRFa. The resulting large, positively charged side chain at this position should 
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impair FRRFa binding if Phe302 were part of the FRRFa binding site. The induction of a sustained current was 
however maintained in F302C-MTSMT and was similar as in F302A (Fig. 4c,d). In control experiments we con-
firmed that exposure of F302C to a positively charged MTS reagent changes its function, indicating thus that the 
Cys residue at this position is modified (Supplementary Fig. S2).
The EC50 of the FRRFa-mediated sustained current induction in F302A was 11 ± 2 μM (n = 8–10), compared 
to 37 ± 15 μM in WT (Fig. 4f). The disappearance of the sustained current followed in this mutant a faster time 
course than in WT (Fig. 4g, p < 0.001), suggesting that FRRFa does not have a higher binding affinity in F302A 
than in WT. Figure 4f illustrates that FRRFa has a higher efficacy on F302A compared to WT, as reflected by the 
Figure 3. Docking results of FRRFa peptide to the thumb base pocket of the desensitized and the closed 
conformation of ASIC1a. The human ASIC1a structural model is based for (a) on a desensitized ASIC1 
structure18, and for (b,c) on the closed ASIC1a structure20. (a) Predicted FRRFa interaction mode with the 
desensitized ASIC1a thumb base pocket. (b,c) Predicted FRRFa interaction mode with the closed ASIC1a 
thumb base pocket in structural view (b) and schematic 2D representation (c). The color code is as described 
in the legend to Fig. 1. Residues that were mutated for the functional analysis are shown in ball and stick 
representation in panels a and b and labelled in bold in all three panels.
Figure 4. Thumb base mutations do not prevent FRRFa modulation of ASIC1a currents. (a) Bar graph of the 
Isust/Ipeak ratio induced by pH5 of WT and thumb base mutants as indicated; grey bars, control; red bars, 50 μM 
FRRFa, n = 4–22. (b) Ratio of FRRFa-induced increase in Isust/Ipeak in the indicated mutants (n = 4–22). For (a–d) 
**p < 0.01, ****p < 0.0001, different from the same condition in WT; #p < 0.05, ##p < 0.01, the FRRFa-induced 
increase in Isust/Ipeak is different from this ratio in WT. (c) Bar graph of the Isust/Ipeak ratio induced by pH5 of WT 
F302C-MT. (d) Ratio of FRRFa-induced increase in Isust/Ipeak in the indicated mutants. For (c,d) the oocytes had 
been exposed during 3 min to 1 mM MTSMT (n = 5) prior to the experiment. (e) Representative current traces 
of ASIC1a-F302A in the absence and presence of 100 μM FRRFa. (f) FRRFa concentration-response curve of the 
Isust/Ipeak current ratio induced by pH5 in oocytes expressing F302A, n = 8. The WT curve is shown for comparison 
(n = 7–11). (g) Time course of disappearance of the FRRFa-induced sustained current in the F302A mutant and 
WT. FRRFa at 50 μM was applied for 45 s, and then washed out. The normalized Isust/Ipeak ratio is plotted as a 
function of time. Exponential fit shown as solid line, n = 9 (F302A) and n = 4 (WT).
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Isust/Ipeak ratio with 1 mM FRRFa of 0.03 ± 0.00 (n = 7) in WT, and 0.17 ± 0.03 in F302A (n = 9, p < 0.001). Thus, 
the stronger Isust/Ipeak increase in F302A is mostly due to an increased efficacy. It seems therefore likely that the 
F302A mutation increases the effect of FRRFa by a mechanism that is independent of the binding.
Potential FRRFa binding sites in the central vestibule. To search for relevant binding positions of 
FRRFa, we also carried out docking experiments with a homology model based on the Mit-toxin-opened ASIC 
structure29. The conformation of most of the ASIC1 ectodomain is very similar in desensitized and open x-ray 
Figure 5. Docking results of FRRFa peptide to the central vestibule of the open and closed conformation 
of ASIC1a. The structural images are for (a,b) from a human ASIC1a model based on the Mit-toxin-opened 
ASIC1 structure29, and for (c–f) from a model of the closed state20. (a) Predicted FRRFa interaction mode 
with the central vestibule of the open ASIC1a. (b) Predicted FRRFa interaction mode with a side cavity of the 
central vestibule of the open ASIC1a. Note that the N terminus is located inside the central vestibule. (c–f) Two 
predicted FRRFa poses in a side cavity of the central vestibule of closed ASIC1a, in structural view (c,e) and 
schematic 2D representation (PoseView, modified as in Fig. 1, d,f). (e,f) For this pose, the Chimera software 
detected additional interactions, not detected by PoseView: a hydrogen bond between Arg3 and the Thr370 
backbone and a hydrogen bond between Phe1 backbone and the Asn416 side chain. The colour code of the 
peptide is the same as described in the legend of Fig. 1. The three ASIC subunits are colored in yellow, red, and 
blue. Residues that were mutated for the functional analysis are are shown in ball and stick representation in 
panels a, b, c and e and labelled in bold in all panels.
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structures, however the distance between subunits is increased at the level of the lower palm and the transmem-
brane domains, leading to an increased volume of the cavities at these levels in the open state26,29. The central ves-
tibule, located between the three palm domains18, is connected in the closed and open conformation to three side 
cavities that open between the subunits (Supplementary Fig. S3). These cavities have a total volume of ∼6500 Å3 
in the open state, whereas the volume of the central vestibule in the desensitized state is only ∼1400 Å3 (CASTp). 
Docking poses were found with high scores in the acidic pocket and the thumb base, and with lower scores in 
the central vestibule. In the highest ranked poses in the central vestibule, both FRRFa Phe side chains points 
upwards, involved in an aromatic stacking interaction with each other (Fig. 5a). Hydrogen bond interactions 
are predicted with residues Glu79, Glu418, Gln276 and Asn416. In an alternative docking position, the FRRFa 
peptide is bound in a side opening of the central vestibule (Fig. 5b), interacting with acidic and other hydrophilic 
ASIC residues in the central vestibule, and with the hydrophobic amino acids Ile307, Val414 and Leu415. In this 
pose, the N-terminal end is however docked inside the central vestibule, thus, a longer RFa peptide could not take 
this pose in the same orientation.
Two binding modes of FRRFa were identified in the closed ASIC1a conformation according to the criteria 
of similar conformations of the RFa moiety of FRRFa and KNFLRFa (Supplementary Fig. S1d). In both poses 
(Fig. 5c–f), FRRFa binds into the side cavities of the central vestibule, in a similar way as previously observed 
from docking to the open conformation (Fig. 5b), with the difference that in the poses on the closed channel, the 
FRRFa N-terminus faces the outside of the side cavities. The two poses on the closed channel differ from each 
other in the positions of the Arg2 side chain and in the backbone of the N-terminal part, whereas the rest of the 
conformation is very similar. Both binding modes have the RFa moiety buried inside, with Phe4 sandwiched 
Figure 6. Mutations of the palm change FRRFa modulation of ASIC1a. Mutants containing “-ET” in their 
name had been exposed during 3 min to 1 mM MTSET prior to the experiment. (a) Representative current 
traces of the mutant E418C in the absence and presence of 50 μM FRRFa. (b) Bar graph of the Isust/Ipeak ratio 
induced by pH5 of WT and mutants as indicated (n = 5–41). For (b,g–i) *p < 0.05; **p < 0.01, ***p < 0.001, 
****p < 0.0001, different from WT. (c) Ratio of 50 μM FRRFa-induced increase in Isust/Ipeak (n = 5–41). (d) 
Ratio of 500 μM FRRFa-induced increase in Isust/Ipeak (n = 5–11). For (b–d) #p < 0.05; ##p < 0.01; ###p < 0.001; 
####p < 0.0001; ratio different from the ratio in WT. (e) FRRFa concentration-response curve of the Isust/Ipeak 
current ratio induced by pH5 in oocytes expressing N416C, n = 8. The WT curve is shown for comparison 
(n = 7–11). (f) Time course of disappearance of the FRRFa-induced sustained current in the N416C mutant and 
in WT. 50 μM FRRFa was applied for 45 s, and then washed out. The normalized Isust/Ipeak ratio is plotted as a 
function of time, and the solid line represents an exponential fit to the data, n = 9 (N416C) and n = 4 (WT). (g) 
pHD50 values obtained in the absence of FRRFa (n = 5–54). (h) The difference in pHD50 (pHD50FRRFa-pHD50ctrl) 
is plotted in the bar graph, n = 5–54. (i) Plot of the ratio nHFRRFa/nHctrl of the SSD pH dependence.
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between Phe263 of one subunit, and Phe411 and Ala274 of the neighbouring subunit, and the amide group inter-
acting with the Glu413 side chain. In one of the poses, Arg2 forms a hydrogen bond with the Glu413 side chain 
(Fig. 5c,d), whereas in the second pose the Arg2 and -3 side chains are involved in hydrogen bonds with the side 
chains of Glu375 and Glu254, respectively (Fig. 5e,f). In both binding modes the N-terminal Phe is placed in the 
hydrophobic pocket formed close to the entrance of the cavity by the side chains of Ile307, Val414 and Leu261. In 
the second pose, the N-terminal amino group forms a hydrogen bond with the Glu79 side chain.
To check the stability of the two poses, they were each subjected to molecular dynamics (MD) simulations of 
20 ns duration (Supplementary Methods). Both peptides remained buried deeply in the pocket until the end of the 
simulation (Supplementary Fig. S4). The RMSD of the peptide backbone atoms between the docking results and 
structures at the end of the simulations was 1.995 Å and 2.720 Å for the poses presented in Fig. 5c–f, respectively. 
The phenyl ring positions were slightly changed, but the interactions with hydrophobic residues in the pocket 
were conserved. In both poses, the amide function and the backbone of the C-terminal RF moiety were stabilized 
by a rich hydrogen bond network with Glu413 and Glu375. In addition, a salt bridge between Arg3 and Glu254 
was formed during the MD simulation in both systems. For the pose shown in Fig. 5c,d, Phe1 interacted with 
Leu369 and Val414 at the end of the simulation, and Arg2 formed hydrogen bond with Glu375, whereas in the 
second pose, Phe1 was located between Phe257 and Ile307, and Arg2 formed a hydrogen bond with the Asn416 
backbone. Although some of the interactions of the peptide with the channel changed in the course of the MD 
simulations, the identified interacting amino acid residues in the central cavity are basically the same in the dock-
ing and at the end of the simulations.
Mutations of several palm residues reduce the FRRFa-induced changes of the sustained current 
and SSD pH dependence. To test the docking predictions, Cys mutants of palm and other proximal resi-
dues predicted to interact with the peptide were made. Since most of these residues are large and hydrophilic, the 
mutation to Cys changed the side chain properties substantially. Therefore, and because MTSET modification of 
many palm residues leads to currents with a large sustained component22 that may render the measurement of 
FRRFa effects difficult, we exposed only the Cys mutants of hydrophobic residues (I307C and V414C) to 1 mM 
MTSET prior to the experiments with FRRFa. Asp212 was mutated to Gly (and not Cys), since we have previously 
observed that this residue is very sensitive to mutation25, and that it is in most ASIC1a orthologs and even in sev-
eral human ASIC1a clones a Gly. Mutations of several palm residues resulted in currents with an increased Isust/Ipeak 
ratio under control conditions (Fig. 6b). FRRFa at 50 μM induced a strong Isust/Ipeak increase in the mutant 
N416C, and had in several mutants, E79C, E413C, V414C-ET and E418C, less effect on the Isust/Ipeak ratio than 
in WT (Fig. 6a–c). This suggests that residues Glu79, Glu413, Val414 and Glu418 interact with FRRFa. The 
FRRFa-induced increase of the Isust/Ipeak ratio was in these mutants smaller than that of WT also at a concentration 
of 500 μM (Fig. 6d). This indicates that these mutations either suppress the effect of FRRFa, or strongly increase its 
EC50. Due to the extremely small FRRFa-induced Isust/Ipeak ratio changes it was not possible to determine the EC50 
of FRRFa on these mutants. To learn more about the nature of the Isust/Ipeak ratio increase by the N416C mutation, 
we measured the EC50 of FRRFa, which was 6 ± 2 μM (Fig. 6e, n = 6–7). Figure 6e also illustrates the higher effi-
cacy of FRRFa on N416C as compared to WT ASIC1a with Isust/Ipeak ratios at 1 mM FRRFa of 0.30 ± 0.04 (n = 7) 
for N416C and 0.03 ± 0.00 (n = 7) for WT (p < 0.0001)). Thus, the increased FRRFa-induced Isust/Ipeak ratio in 
N416C compared to the WT is mostly due its higher efficacy on the mutant channel. The time course of the dis-
appearance of the sustained current was not different between the N416C mutant and WT (Fig. 6f, koff(N416C) = 0.
027 ± 0.003 s−1, n = 9, compared to koff(WT) = 0.029 ± 0.011, n = 4, in the direct comparison).
The pHD50 was shifted with regard to WT by many of these mutations already under control conditions 
(Fig. 6g). The FRRFa-induced shift in pHD50 was decreased in about half of the mutants, while in one of them, 
R371C, FRRFa induced a larger shift (Fig. 6h). Several mutations prevented the FRRFa-induced decrease of the 
steepness of the SSD pH dependence (Fig. 6i). Together, the effects of the mutations on the two ASIC properties 
(Table 1) strongly suggest an involvement of the palm in FRRFa binding.
Discussion
Based on in silico docking, mutagenesis and functional validation, our study points to the side cavities of the cen-
tral vestibule as the most probable binding sites for the peptide FRRFa. Previous observations resulted in hypoth-
eses about the sites of action of RFa peptides in ASIC1a. One study showed a competition between the functional 
effects of PcTx1 and the peptide big dynorphin (a remotely related Arg-rich 32-amino acid peptide), which mod-
ulates ASIC1a in a similar way as RFa peptides do32. The 40-amino acid peptide toxin PcTx1 binds into the acidic 
pocket and to the subunit interface adjacent to it26,33,34. The observed competition may indicate a competition for 
the same binding site, thus that big dynorphin and possibly also RFa peptides bind to the acidic pocket or close to 
it. However, it also needs to be considered that PcTx1 and the neuropeptides have opposite functional effects on 
SSD35,36 and therefore, the observed antagonism may be entirely functional, with PcTx1 and big dynorphin bind-
ing to different sites on ASICs. In another study, the team of Askwith focused on the residue Leu280 of the palm. 
On the L280C mutant, MTSET modification strongly increases the sustained current fraction16,22. It was shown 
that 1) in the presence of FRRFa, the modification of L280C by MTSET was slowed, and 2) the FRRFa-induced 
increase in Isust/Ipeak ratio was diminished if the channels had previously been exposed to MTSET16. This indicated 
that FRRFa interferes with conformational changes in the palm, or may impair the association of MTSET with 
L280C. A very recent study that applied docking and mutagenesis, suggests the central vestibule as binding site of 
the related peptide RPRFa on ASIC337.
Two mutations in two different regions, F302A of the thumb base pocket and N416C of the palm, boosted the 
FRRFa-induced increase of the sustained current. They did so mostly by increasing the efficacy of FRRFa, indi-
cating that the mutations did not profoundly change the binding of FRRFa, but rather the consequences of FRRFa 
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binding. While Asn416 is located close to our predicted FRRFa binding site, Phe302 is located in the thumb base 
pocket, for which we did not find any functional evidence as being an FRRFa binding site. Both residues are 
located in domains that have previously been linked to desensitization. It was shown that differences in the β9-α4 
palm-thumb loop sequence – where Phe302 is located - are at the origin of differences in desensitization between 
mouse and human ASIC1a28. The palm is critically involved in desensitization16,22,23,25,38. Asn416 (corresponding 
to Asn415 in chicken ASIC1), located in the β11-β12 loop of the palm, was shown to change its side chain ori-
entation by ∼180° between the open and desensitized state26. Replacement of Asn416 by positively charged side 
chains slows desensitization by a stabilization of the open state due to an interaction with Glu7922. Since Asp416 is 
critically involved in the conformational change during the open → desensitized transition, the N416C mutation 
may affect the equilibrium or the energy barrier between the open and the desensitized state, an effect that might 
be potentiated by FRRFa, leading to the observed increased Isust/Ipeak ratio.
Our docking experiments that were the basis for the choice of mutations were carried out with models of 
the open and desensitized ASIC1a19,29. In the experimental setting, binding of FRRFa occurs mostly to closed 
channels, since the peptide has to be pre-applied due to its low association rate. A crystal structure of a closed 
ASIC has been published very recently20. Comparison of FRRFa docking results shows that the mutations of the 
thumb base pocket and the central vestibule that were tested in functional experiments cover the predicted inter-
acting residues reasonably well. In the acidic pocket in contrast, the closed state poses were different from those 






E97 H-bond with Arg2 or Arg3 < = =
D237 H-bond desensitized state = N.D. N.D.
S240 H-bond with Phe4 and C-terminal amide = N.D. N.D.
E242 H-bond with Phe4 = = =
D347 Proximity, electrostatic I. desensitized state < = =
D351 Proximity, electrostatic I. desensitized state = = =
E355 Proximity, electrostatic I. desensitized state = = =
Thumb base cavity
V187 Hydrophobic I., desensitized state = N.D. N.D.
S199 H-bond with C-terminal amide > N.D. N.D.
D253 Hydrophobic I. desensitized state = N.D. N.D.
E254 Proximity = = >
F257 Stacking I. desensitized state = N.D. N.D.
F301 (Backbone) H-bond with N-terminal NH2-group = N.D. N.D.
F302 Stacking I. with Phe4 > N.D. N.D.
D303 Electrostatic I. desensitized state = = =
I312 Hyrophobic I., desensitized state = = =
E315 Electrostatic I. desensitized state = N.D. N.D.
Central vestibule and side cavities
E79CV H-bond N-terminal NH2-group < = =
D212CV Proximity = < =
Q276CV H-bond open state = < >
Q278CV H-bond open state = < >
I307SC Hydrophob. I. with Phe1 = < >
R371CV Hydrophob. I. with Arg2; H-bond open state = > >
E375CV H-bond Arg2 = = =
E413CV H-bond C-term amide; H-bond Arg2 < = =
V414SC Hydrophob. I. Phe1 < < >
N416SC H-bond Phe1 > = =
E418CV H-bond open state < = >
Table 1. Summary of effects of mutations on FRRFa-induced ASIC modulation. *For residues of the central 
vestibule and its side cavities, indication of the localization, as CVcentral vestibule; SCside cavity. &if not noted 
otherwise, docking predictions are from the closed state docking. For § and $the signs indicate whether FRRFa 
changed this parameter in a different way in the mutant as compared to the WT; =, no significant difference. 
§<, smaller Isust/Ipeak change induced by FRRFa in the mutant with regard to WT, (>, the opposite). $ΔpHD50, 
<, smaller Δ(pHD50,FRRFa − pHD50,Ctrl) than in WT, (>, the opposite); the nHSSD ratio, nHSSD,FRRFa/nHSSD,ctrl, is 
∼0.5 in WT, and a higher value in a mutant than in the WT means that there is less change in the mutant; >, 
nHSSD,FRRFa/nHSSD,ctrl of the mutant is higher than this ratio in WT, (<, the opposite). Electrostatic I., electrostatic 
interaction; Hydrophob I., hydrophobic interaction; Stacking I., stacking interaction; N.D., not determined.
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obtained in the desensitized conformation. Therefore, there was less coverage by the mutagenesis approach of the 
interacting residues predicted from docking to the closed state. However, several tested acidic pocket residues, 
Glu97, Asp237, Ser240 and Glu242 are part of the FRRFa binding sites predicted from docking to the closed 
conformation. Since we mutated these and the other residues of the acidic pocket to Cys and modified them 
with MTSET that results in a positively charged adduct, these mutations/modifications should have impaired 
the effects of FRRFa if they depended on binding to the acidic pocket. Cys mutants at several of these positions 
(Asp237, Asp347, Asp351 and Glu355) were previously shown to be modified by large, Cys-reactive dyes25, prov-
ing the accessibility of these residues for MTSET. We show that exposure to MTSET changes the properties of 
the mutants E97C, S240C and E242C (Supplementary Fig. S2), indicating therefore that MTSET modifies these 
residues and adds a positive charge into the acidic pocket. Of the combined mutations/modifications in the acidic 
pocket, only two (E97C-ET and D347C-ET) prevented the FRRFa-induced increase in the Isust/Ipeak ratio, and 
none affected the pH dependence of SSD. In contrast to the acidic pocket, 5 of 11 generally more conservative 
mutations in the central vestibule and its side cavities affected the FRRFa-induced increase in the Isust/Ipeak ratio, 
and 7/11 changed the FRRFa-induced modification of the SSD (Table 1). Thus, we show here a much stronger 
involvement of the central vestibule and its side cavities than the acidic pocket in the effects of FRRFa. The MD 
simulations carried out for the peptide poses in the central vestibule of the closed ASIC1a model confirmed a sta-
ble binding of the peptide to this pocket. During the simulations, some changes of the side chain positions of Phe1 
and Arg2 occurred. The position of the RF moiety changed however only slightly, and the interacting residues in 
the central cavity were the same in the docking and at the end of the MD simulation.
The functional analysis validated several, but not all of the interactions predicted by the docking in the cen-
tral vestibule and its side cavities. A certain imprecision in the docking might be one reason for the incomplete 
matching of the docking and experimental findings, because it was done with a rigid homology model and did not 
take into account protein dynamics and flexibility that may influence the channel-peptide interactions. The MD 
simulations carried out with the docking poses to the central vestibule and its side cavities of the closed ASIC1a 
model did however not identify other interacting residues. Given the relatively low apparent affinity of FRRFa 
on ASIC1a, it is also expected that there are not many strong interactions between the peptide and the channel.
The reduction of FRRFa effects by ASIC1a mutations can in principle be caused by an impairment of binding, 
or of the steps linking FRRFa binding to changed ASIC function. The functional analysis cannot distinguish 
between these two possibilities. However, based on the combination of 1) the computational prediction of bind-
ing and 2) the functional effects, our data strongly suggest that the identified residues of the central vestibule and 
its side cavities are part of the FRRFa binding site or control its access.
Methods
Computational methods. The docking was carried out to human ASIC1a models of the desensitized, open 
and closed conformations, based on crystal structures of chicken ASIC1 that shares 90% sequence identity with 
human ASIC1a. For the desensitized conformation, we used a previously published structural model of human 
ASIC1a23, based on the crystal structure PDB ID 2QTS that represents a desensitized channel18. The human 
ASIC1a model of the open channel conformation was based on the PDB ID 4NTW crystal structure of chicken 
ASIC complexed with Mit-toxin29. The model of ASIC1a in the closed conformation was based on the 5WKU 
chicken ASIC structure20. Modeller software version 9.1339 was used to produce the homology models, in the 
same way as the desensitized channel model had been created23. In desensitized and open ASIC1a models the 
chloride ions were placed between the residues Arg311, Glu315 and Lys211, in analogy to the position of chloride 
in the chicken ASIC1 crystal structure18. Only the extracellular part (residues Val65 to Leu432) of the channel 
subunits was taken into account during the docking procedure. The protonation state of individual acidic residues 
was adjusted to the values at pH7.4 or pH5, according to their effective pKa values calculated previously23. The 
docking runs were performed with the channel’s acidic residues protonated according to calculated pKa values23 
to mimic either the physiological pH7.4 (all three models) or the acidic pH5 (for the open and desensitized 
model). Both Arg residues of FRRFa are expected to be protonated at these pH values. Since the docking results 
were not different between the two protonation states, results of the docking to the desensitized and open chan-
nel are shown for a protonation state corresponding to pH5 (since these functional states occur at acidic pH), 
while results with the closed state model are shown for a protonation state of pH7.4. The docking was performed 
with AutoDock Vina40, version 1.1.2. The search was performed in all three subunits. The docking was repeated 
using each time different alpha carbon coordinates of 12 residues (Thr236, Gln278, Ile312, Lys380 from all three 
chains) as a search box center to ensure that the search space covered the entire extracellular part of the channel 
(Supplementary Fig. S5). The side length of the cubic box in which the search was performed was set to 35 Å, and 
the exhaustiveness parameter was set to 1000. Residues of the channel protein were kept rigid during docking.
The results of all dockings were grouped and sorted according to Vina’s internal ranking. The best poses of 
the ligand according to Vina were identified and their interactions with ASIC1a investigated to choose the best 
candidates for mutagenesis. In the case of desensitized and open channel conformations, the chosen poses ful-
filled in addition the criterion of the peptide N-terminus pointing towards the entrance. In the case of closed state 
ASIC model docking, the filtering of the most probable poses was done using the docking results of the KNFLRFa 
peptide to the same channel conformation. The poses of FRRFa peptide with an energy score within a range of 
1 kcal/mol from the best scored pose were compared with poses of the KNFLRFa peptide. The similarity of RFa 
moiety binding was measured by calculating the RMSD value over 9 heavy atoms in the peptides’ RFa groups 
(backbone Cα, N, side chain CZ, CG and amide NT). The conformations of FRRFa with a RMSD value lower than 
1 Å were considered as similar to one of the KNFLRFa peptide and were chosen as the most relevant poses for 
further investigation. The docking results of FRRFa and KNFLRFa to the closed state of ASIC1a are available in 
the following form at the zenodo repository with the doi 10.5281/zenodo.1478585: The docking result files “FRRF.
dock4” and “KNFLRF.dock4” can be opened together with the provided structural file “closed_ASIC_pH7.4.pdb” 
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for instance with the UCSF Chimera software41. The pdb file “FRRF_KNFLRF_complexes.pdb“ represents the 
selected binding modes of FRRFa and KNFLRFa peptides in which the RF groups have similar binding positions. 
The docking results were visualized and analysed with UCSF Chimera. The channel-peptide interactions were 
represented in a schematic way using PoseView42. The volume of cavities was calculated with CASTp30 with a 
probe size parameter of 1.4 Å, which determines the solvent-accessible volume. It was not possible to determine 
the volume of the acidic pocket in the closed state with this probe size, since the acidic pocket is connected in 
the closed state to other cavities. To determine the fold change in volume of the acidic pocket between different 
functional states we used therefore a probe size of 2.0.
Site-directed mutagenesis and expression in Xenopus oocytes. Human ASIC1a43 had been sub-
cloned into a vector for transcription that contained 5′- and 3′-untranslated regions of Xenopus β-globin mRNA44. 
Point mutations were introduced using QuikChange (Agilent, Basel, Switzerland). Mutations were verified by 
sequencing (Synergene Biotech, Zurich, Switzerland). Expression in Xenopus laevis oocytes was carried out as 
described previously44. Complementary RNAs were synthesized in vitro (mMESSAGE mMACHINE® SP6 kit, 
Ambion/Life Technologies, Zug, Switzerland). Oocytes were surgically removed from the ovarian tissue of female 
Xenopus laevis, which had been anesthetized by immersion in MS-222 (2 g l−1; Sandoz, Basel, Switzerland). The 
oocytes were defolliculated, and healthy stage V and VI Xenopus oocytes were isolated and pressure-injected with 
10 ng of cRNA or as indicated, and oocytes were kept in modified Barth saline (composed of (in mM) 85 NaCl, 
1 KCl, 2.4 NaHCO3, 0.33 Ca(NO3)2, 0.82 MgSO4, 0.41 CaCl2, 10 HEPES, 4.08 NaOH) during the expression 
phase. All experiments with Xenopus laevis were carried out in accordance with the Swiss law on animal welfare, 
following protocols that had been approved by the committee on animal experimentation of the Canton de Vaud.
Electrophysiological Analysis. Electrophysiological measurements were performed 1–2 days after cRNA 
injection. Ion currents were recorded using two-electrode voltage-clamp at a holding potential of −60 mV with a 
Dagan TEV-200 amplifier (Minneapolis, MN). Oocytes were placed in a recording chamber (300 μl) and perfused 
by gravity at ∼8 ml/min. Acidic (stimulation) solutions were applied once every minute for 5 s for the measure-
ments of the pH dependence of SSD, and between stimulations the recording chamber was perfused with the 
conditioning solution. For the measurement of the Isust/Ipeak ratio, the pH5 solution was generally applied for 10 s, 
and for mutants that showed a tendency to slower desensitization, for up to 20 s, to allow reaching of a steady-state 
sustained current. In the “FRRFa condition”, FRRFa was present in the conditioning pH solution and in the pH5 
stimulation solution. When longer exposure to pH5 was chosen, the interval between the start of subsequent 
stimulations was increased, to expose the oocyte for at least 45 s to the conditioning solution at pH7.4 between the 
pH5 stimulations. The amplitude of the sustained current was measured in the last two seconds of the pH5 perfu-
sion. Since we observed some day-to-day variation in the effects of FRRFa, we carried out on each experimental 
day in addition to the mutants, also experiments with WT ASIC1a. Data of mutants are presented together with 
the corresponding data obtained from WT at the same experimental days. The standard bath solution contained 
in mM, 110 NaCl, 2 CaCl2, 10 HEPES-NaOH (or MES- NaOH for pH < 6.8), 0.05% BSA, and the pH was adjusted 
with NaOH to the indicated values. The pipette solution contained 1 M KCl. Pipettes were pulled from borosilicate 
glass (Kimble Glass Inc., Germany). Kaleidagraph (Synergy software) or GraphPad Prism (GraphPad software, La 
Jolla; USA) was used to fit the pH - SSD curves to the Hill equation: I = Imax*(1 − (1/(1 + (10−pHD50/10−pH)nH))), 
where Imax is the maximal current, pHD50 is the pH that induces half-maximal desensitization, and nH is the Hill 
coefficient. Since our setup allows switching between 8 different solutions, and two solutions are required per con-
centration, FRRFa concentration-response curves were constructed based on measurements made with different 
FRRFa concentration ranges from different cells. Concentration-response curves were fitted to a Hill-Langmuir 
equation. Data are presented as mean ± SEM. Differences between WT and mutant forms of ASIC1a and between 
different treatments were analyzed by ANOVA or Kruskal Wallis, followed by Dunnett’s or Dunn’s post hoc test, 
using Prism.
Reagents. FRRFa was synthesized and lyophilized by the protein and peptide chemistry facility of the 
University of Lausanne or by Genescript (Hong Kong, China). Methanethiosulfonate reagents were obtained from 
Toronto Research Chemicals (North York, Canada), and other reagents were from Sigma, Fluka, or Applichem.
Data Availability
The Autodock Vina results of the docking of FRRFa and KNFLRFa peptides to the ASIC1a model in the closed 
conformation that can be visualised on the closed ASIC1a model, as well as the structures of selected poses of FR-
RFa and KNFLRFa peptides docked to the closed conformation of the ASIC1a model, are available at the Zenodo 
repository at https://zenodo.org/record/1478585. Other data sets are available upon request.
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